These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19889950)

  • 1. Should the PANSS be rescaled?
    Obermeier M; Mayr A; Schennach-Wolff R; Seemüller F; Möller HJ; Riedel M
    Schizophr Bull; 2010 May; 36(3):455-60. PubMed ID: 19889950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia.
    Ruberg SJ; Chen L; Stauffer V; Ascher-Svanum H; Kollack-Walker S; Conley RR; Kane J; Kinon BJ
    BMC Psychiatry; 2011 Feb; 11():23. PubMed ID: 21306626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subscale structure for the Positive and Negative Syndrome Scale (PANSS): a proposed solution focused on clinical validity.
    Kelley ME; White L; Compton MT; Harvey PD
    Psychiatry Res; 2013 Jan; 205(1-2):137-42. PubMed ID: 22974521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PANSS should be rescaled.
    Leucht S; Kissling W; Davis JM
    Schizophr Bull; 2010 May; 36(3):461-2. PubMed ID: 20357133
    [No Abstract]   [Full Text] [Related]  

  • 5. The positive and negative syndrome scale (PANSS) for schizophrenia.
    Kay SR; Fiszbein A; Opler LA
    Schizophr Bull; 1987; 13(2):261-76. PubMed ID: 3616518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on the Positive and Negative Syndrome Scale (PANSS): Use, misuse, drawbacks, and a new alternative for schizophrenia research.
    Aboraya A; Nasrallah HA
    Ann Clin Psychiatry; 2016 May; 28(2):125-31. PubMed ID: 26855990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PANSS-6: a brief rating scale for the measurement of severity in schizophrenia.
    Østergaard SD; Lemming OM; Mors O; Correll CU; Bech P
    Acta Psychiatr Scand; 2016 Jun; 133(6):436-44. PubMed ID: 26558537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the PANSS used correctly? a systematic review.
    Obermeier M; Schennach-Wolff R; Meyer S; Möller HJ; Riedel M; Krause D; Seemüller F
    BMC Psychiatry; 2011 Jul; 11():113. PubMed ID: 21767349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to assess response.
    Zitzmann S; Lindner C
    Eur Arch Psychiatry Clin Neurosci; 2024 Jun; ():. PubMed ID: 38839710
    [No Abstract]   [Full Text] [Related]  

  • 10. OXTR polymorphisms associated with severity and treatment responses of schizophrenia.
    Lv X; Hou YS; Zhang ZH; Yue WH
    Schizophrenia (Heidelb); 2024 Jan; 10(1):7. PubMed ID: 38184684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are informants required to obtain valid ratings on the Positive and Negative Syndrome Scale (PANSS)?
    Nielsen CM; Kølbæk P; Dines D; Opler M; Correll CU; Østergaard SD
    Schizophrenia (Heidelb); 2023 Aug; 9(1):54. PubMed ID: 37653026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients.
    Li Z; Zong X; Li D; He Y; Tang J; Hu M; Chen X
    BMC Psychiatry; 2023 Jan; 23(1):45. PubMed ID: 36650462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylome-wide association study of different responses to risperidone in schizophrenia.
    Du H; Ma J; Zhou W; Li M; Huai C; Shen L; Wu H; Zhao X; Zhang N; Gao S; Wang Q; He L; Wu X; Qin S; Zhao M
    Front Pharmacol; 2022; 13():1078464. PubMed ID: 36618913
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study.
    Pappa S; Kalniunas A; Sharma H; Raza-Syed A; Kamal M; Larkin F
    Ther Adv Psychopharmacol; 2022; 12():20451253221132087. PubMed ID: 36439679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial.
    Tang Y; Wu Y; Li X; Hao Q; Deng W; Yue W; Yan H; Zhang Y; Tan L; Chen Q; Yang G; Lu T; Wang L; Yang F; Zhang F; Yang J; Li K; Lv L; Tan Q; Zhang H; Ma X; Li L; Wang C; Ma X; Zhang D; Yu H; Zhao L; Ren H; Wang Y; Zhang G; Li C; Du X; Hu X; Li T; Wang Q
    Curr Neuropharmacol; 2023; 21(2):424-436. PubMed ID: 36411567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study.
    Millgate E; Griffiths K; Egerton A; Kravariti E; Casetta C; Deakin B; Drake R; Howes OD; Kassoumeri L; Khan S; Lankshear S; Lees J; Lewis S; Mikulskaya E; Oloyede E; Owens R; Pollard R; Rich N; Smart S; Segev A; Verena Sendt K; MacCabe J;
    BMJ Open; 2022 Nov; 12(11):e062570. PubMed ID: 36410817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-intensity interval training may reduce depressive symptoms in individuals with schizophrenia, putatively through improved VO
    Bang-Kittilsen G; Engh JA; Holst R; Holmen TL; Bigseth TT; Andersen E; Mordal J; Egeland J
    Front Psychiatry; 2022; 13():921689. PubMed ID: 36003983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports.
    Hodkinson A; Heneghan C; Mahtani KR; Kontopantelis E; Panagioti M
    BMC Med; 2021 Aug; 19(1):195. PubMed ID: 34429113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Efficacious Are Antipsychotic Drugs for Schizophrenia? An Interpretation Based on 13 Effect Size Indices.
    Leucht S; Siafis S; Engel RR; Schneider-Thoma J; Bighelli I; Cipriani A; Furukawa TA; Davis JM
    Schizophr Bull; 2022 Jan; 48(1):27-36. PubMed ID: 34405881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Dynamics in Degree Centrality of Brain Functional Connectome in First-Episode Schizophrenia with Different Short-Term Treatment Responses: A Longitudinal Study.
    Wang Y; Jiang Y; Su W; Xu L; Wei Y; Tang Y; Zhang T; Tang X; Hu Y; Cui H; Wang J; Yao D; Luo C; Wang J
    Neuropsychiatr Dis Treat; 2021; 17():1505-1516. PubMed ID: 34079256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.